Ritz Crackers Recall: Peanut Allergy Risk Prompts Urgent Action in 8 States

Why Are Ritz Crackers Being Recalled?

For millions of Americans, Ritz Crackers are a familiar comfort—a staple tucked away in lunchboxes, kitchen drawers, and office snack corners. But this week, a routine grab for a quick bite could carry unexpected danger for those with peanut allergies. On November 28, 2025, Mondelēz Global LLC, the snack giant behind Ritz, announced a voluntary recall of 70 cases of Ritz Peanut Butter Cracker Sandwiches shipped to eight states. The culprit: a labeling error that could turn a snack into a serious health risk.

The issue is deceptively simple but potentially life-threatening. While the outer packaging of these crackers correctly indicates “Peanut Butter” and includes a clear allergen advisory, the individually wrapped sleeves inside may be mislabeled as “Cheese.” For consumers who rely on accurate labels to avoid allergens, this mix-up poses significant risk.

What Is the Scope of the Recall?

The recall affects select 20-count boxes of Ritz Peanut Butter Cracker Sandwiches bearing the UPC 44000 07584 2 and “best by” dates of January 8, 619, and January 15, 2026. These products were distributed in Alabama, Arkansas, Georgia, Oklahoma, Pennsylvania, Missouri, New York, and New Jersey. Importantly, no other Ritz products are impacted, and the recall does not extend beyond these specified states and batch numbers.

Mondelēz has emphasized that this recall is not an expansion of a previous recall from July 2025, which involved a similar mislabeling issue. Rather, the current action is taken “out of an abundance of caution,” according to company statements cited by People and KARE 11.

How Serious Is the Allergy Risk?

The U.S. Food and Drug Administration (FDA) has weighed in, underscoring the gravity of peanut allergies. Even minute exposure can trigger reactions ranging from coughing and hives to severe symptoms like facial swelling, loss of consciousness, and in extreme cases, death. The FDA’s advisory is clear: anyone with a peanut allergy should avoid consuming these crackers and immediately discard any affected packages.

Fortunately, as of publication, Mondelēz reports no injuries or illnesses linked to the recall. Still, the company and federal regulators urge caution, as allergic reactions can escalate rapidly and unpredictably. The reliability of food labeling is often the first line of defense for families managing allergies, making mislabeling a critical concern.

What Should Consumers Do?

If you’ve purchased Ritz Peanut Butter Cracker Sandwiches in the specified states and date ranges, check the packaging closely. While the outer carton is correctly labeled, pay particular attention to the individual sleeves inside. If you—or anyone in your household—has a peanut allergy, do not consume the product.

Mondelēz has set up a dedicated hotline (1-844-366-1171) for questions, available weekdays from 9 a.m. to 6 p.m. Eastern Time. Consumers are encouraged to call for more information or to report any concerns. The company also reminds the public that the recall is voluntary and proactive, with the FDA kept fully informed throughout the process.

Industry Context: Labeling Errors and Consumer Safety

This latest Ritz recall echoes a similar incident from July 2025, where mislabeling prompted a nationwide recall of cracker sandwiches. Both events highlight a persistent challenge for food manufacturers: ensuring that every step of production, packaging, and distribution upholds stringent safety standards, especially for allergens.

Labeling errors may seem minor, but for those living with severe allergies, they’re anything but trivial. The consequences can be immediate and devastating. For brands like Ritz, the stakes are high—not just for consumer safety, but also for trust. As snack foods continue to be produced and distributed at massive scale, these recalls serve as a stark reminder of the importance of vigilance at every level of the supply chain.

What Happens Next?

At present, there have been no reported cases of illness or injury connected to the affected Ritz products. The recall remains limited to the identified batches and states, with no plans for further expansion unless new information emerges. Mondelēz’s swift action and transparency have drawn praise from some consumer advocates, who note that voluntary recalls are a sign of responsible corporate conduct.

For now, the message from both Mondelēz and the FDA is simple: if you’re at risk, don’t take chances. Discard affected products and contact the company if you have any doubts. As food safety continues to evolve, consumers and manufacturers alike must remain alert to the risks and responsibilities embedded in every snack.

This recall story is a vivid illustration of how even a seemingly minor mistake can ripple across households and communities. The stakes are higher than a missed snack—they’re about trust, safety, and the unseen vulnerabilities that shape everyday choices. The swift, transparent response from Mondelēz and the FDA sets an industry example, but it also reinforces the need for constant vigilance in food production, especially when lives are literally on the line.